Developing Optimal Strategies for Reducing Morbidity in Patients with Non-Cystic Fibrosis Bronchiectasis
Developing Optimal Strategies for Reducing Morbidity in Patients with Non-Cystic Fibrosis Bronchiectasis
Case-based EducationThis case-based morbidity and mortality review (MMR) assesses the negative implications of suboptimal therapeutic management for patients with non-cystic fibrosis bronchiectasis. Cases and expert discussion focus on ensuring a prompt and accurate diagnosis of bronchiectasis, understanding the benefits of high frequency chest wall oscillation (HFCWO), and identifying patients who can benefit from HFCWO.
Faculty: Ashwin Basavaraj, MD, FCCP, ATSF; Colin Swenson, MD
Release Date:
Expiration Date: July 18, 2024
CME/CE is no longer available for this activity
